Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026)
Alx Oncology Holdings (ALXO) posted Prepaid Assets of $295000.0 for Q1 2026, down 72.4% sequentially from $1.1 million in Q4 2025, and down 93.72% YoY from $4.7 million in Q1 2025.
Analysis
Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026) Analysis & Trends
Alx Oncology Holdings has reported Prepaid Assets for 8 years, with the latest figure at $295000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 93.72% year-over-year to $295000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $295000.0 (down 93.72% YoY) and the FY2025 annual result came in at $1.1 million, up 3859.26% from the prior year.
- Prepaid Assets eased to $295000.0 in Q1 2026 per ALXO's latest filing, from $1.1 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $10.4 million in Q1 2024 and troughed at $27000.0 in Q4 2024.
- A 5-year average of $3.5 million and a median of $3.5 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets plunged 95.57% in 2024, then jumped 3859.26% in 2025.
- Over 5 years, Prepaid Assets stood at $4.8 million in 2022, then plunged by 87.21% to $609000.0 in 2023, then tumbled by 95.57% to $27000.0 in 2024, then surged by 3859.26% to $1.1 million in 2025, then slumped by 72.4% to $295000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $295000.0, $1.1 million, and $892000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Alx Oncology Holdings | 272.64 Mn | 272.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.23 Mn |
| Mar 31, 2026 | 5.24 Mn |
| Dec 31, 2025 | 5.94 Mn |
| Sep 30, 2025 | 5.89 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 6.60 Mn |
| Sep 30, 2024 | 7.32 Mn |
| Jun 30, 2024 | 11.99 Mn |
| Mar 31, 2024 | 10.43 Mn |
| Dec 31, 2023 | 5.92 Mn |
| Sep 30, 2023 | 9.06 Mn |
| Jun 30, 2023 | 6.73 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 5.90 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 4.93 Mn |
| Dec 31, 2021 | 3.35 Mn |
| Sep 30, 2021 | 3.81 Mn |